Sterols and oxysterols in immune cell function

Nature Immunology

Volumn 14, Issue 9, 2013, Pages 893-900

  Spann, Nathanael J ^a   Glass, Christopher K ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; OXYSTEROL; RETINOID X RECEPTOR; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL MIGRATION; CHOLESTEROL SYNTHESIS; DNA SEQUENCE; FATTY ACID SYNTHESIS; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LIPID TRANSPORT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION INITIATION; VIRUS ENTRY;

ANIMALS; HUMANS; IMMUNE SYSTEM; STEROLS;

EID: 84883181808     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2681     Document Type: Review

References (95)

1. Brown, M.S. & Goldstein, J.L. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 50 (suppl.), S15-S27 (2009).
2. Tontonoz, P. & Mangelsdorf, D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17, 985-993 (2003).
3. Bensinger, S.J. et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134, 97-111 (2008).
4. Janowski, B.A. et al. Structural requirements of ligands for the oxysterol liver X receptors LXR? and LXR?. Proc. Natl. Acad. Sci. USA 96, 266-271 (1999).
5. Radhakrishnan, A., Ikeda, Y., Kwon, H.J., Brown, M.S. & Goldstein, J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA 104, 6511-6518 (2007).
6. A-Gonzalez, N. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245-258 (2009).
7. Chow, O.A. et al. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8, 445-454 (2010).
8. Blanc, M. et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38, 106-118 (2013).
9. Liu, S.Y. et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38, 92-105 (2013).
10. Bauman, D.R. et al. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. USA 106, 16764-16769 (2009).
11. Hannedouche, S. et al. Oxysterols direct immune cell migration via EBI2. Nature 475, 524-527 (2011).
12. Liu, C. et al. Oxysterols direct B-cell migration through EBI2. Nature 475, 519-523 (2011).
13. Mangelsdorf, D.J. & Evans, R.M. The RXR heterodimers and orphan receptors. Cell 83, 841-850 (1995).
14. Sacchetti, P. et al. Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell 5, 409-419 (2009).
15. Hong, C. & Tontonoz, P. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr. Opin. Genet. Dev. 18, 461-467 (2008).
16. Wagner, B.L. et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell Biol. 23, 5780-5789 (2003).
17. Glass, C.K. & Rosenfeld, M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121-141 (2000).
18. Ghisletti, S. et al. Parallel SUMOylation-dependent pathways mediate gene-and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25, 57-70 (2007).
19. Collins, J.L. et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J. Med. Chem. 45, 1963-1966 (2002).
20. Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J. & Tontonoz, P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219 (2003).
21. Venkateswaran, A. et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97, 12097-12102 (2000).
22. Laffitte, B.A. et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 98, 507-512 (2001).
23. Kennedy, M.A. et al. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 276, 39438-39447 (2001).
24. Spann, N.J. et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151, 138-152 (2012).
25. Zhang, Y. et al. Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule. Am. J. Physiol. Renal Physiol. 290, F1065-F1073 (2006).
26. Shen, Q. et al. Liver X receptor-retinoid X receptor (LXR-RXR) heterodimer cistrome reveals coordination of LXR and AP1 signaling in keratinocytes. J. Biol. Chem. 286, 14554-14563 (2011).
27. Qin, Y., Dalen, K.T., Gustafsson, J.A. & Nebb, H.I. Regulation of hepatic fatty acid elongase 5 by LXR?-SREBP-1c. Biochim. Biophys. Acta 1791, 140-147 (2009).
28. Repa, J.J. et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR? and LXR?. Genes Dev. 14, 2819-2830 (2000).
29. Yang, C. et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J. Biol. Chem. 281, 27816-27826 (2006).
30. Chen, W., Chen, G., Head, D.L., Mangelsdorf, D.J. & Russell, D.W. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5, 73-79 (2007).
31. Glass, C.K. & Saijo, K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 10, 365-376 (2010).
32. Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721 (2005).
33. Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124-1136 (2007).
34. Oh, D.Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698 (2010).
35. Jakobsson, T., Treuter, E., Gustafsson, J.A. & Steffensen, K.R. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol. Sci. 33, 394-404 (2012).
36. Cui, G. et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 121, 658-670 (2011).
37. Zelcer, N. et al. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc. Natl. Acad. Sci. USA 104, 10601-10606 (2007).
38. Dai, Y.B., Tan, X.J., Wu, W.F., Warner, M. & Gustafsson, J.A. Liver X receptor ? protects dopaminergic neurons in a mouse model of Parkinson disease. Proc. Natl. Acad. Sci. USA 109, 13112-13117 (2012).
39. Castrillo, A. et al. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12, 805-816 (2003).
40. Fontaine, C. et al. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ. Res. 101, 40-49 (2007).
41. Im, S.S. et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13, 540-549 (2011).
42. Novelli, G. & D'Apice, M.R. Protein farnesylation and disease. J. Inherit. Metab. Dis. 35, 917-926 (2012).
43. Endo, A., Kuroda, M. & Tanzawa, K. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72, 323-326 (1976).
44. Goldstein, J.L. & Brown, M.S. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29, 431-438 (2009).
45. Pahan, K., Sheikh, F.G., Namboodiri, A.M. & Singh, I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100, 2671-2679 (1997).
46. Niessner, A. et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 189, 408-413 (2006).
47. Liao, J.K. & Laufs, U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89-118 (2005).
48. Kruger, P., Fitzsimmons, K., Cook, D., Jones, M. & Nimmo, G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 32, 75-79 (2006).
49. Thomsen, R.W. et al. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch. Intern. Med. 168, 2081-2087 (2008).
50. Liappis, A.P., Kan, V.L., Rochester, C.G. & Simon, G.L. The effect of statins on mortality in patients with bacteremia. Clin. Infect. Dis. 33, 1352-1357 (2001).
51. Ando, H., Takamura, T., Ota, T., Nagai, Y. & Kobayashi, K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J. Pharmacol. Exp. Ther. 294, 1043-1046 (2000).
52. Chaudhry, M.Z., Wang, J.H., Blankson, S. & Redmond, H.P. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg. Infect. (Larchmt) 9, 183-194 (2008).
53. Liao, Y.H. et al. HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation. J. Leukoc. Biol. 93, 289-299 (2013).
54. Montero, M.T. et al. Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells. Atherosclerosis 153, 303-313 (2000).
55. Xu, J.F. et al. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am. J. Respir. Crit. Care Med. 185, 547-556 (2012).
56. Frenkel, J. et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 46, 2794-2803 (2002).
57. Montero, M.T., Matilla, J., Gomez-Mampaso, E. & Lasuncion, M.A. Geranylgeraniol regulates negatively caspase-1 autoprocessing: implication in the Th1 response against Mycobacterium tuberculosis. J. Immunol. 173, 4936-4944 (2004).
58. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-?. Mol. Cell 10, 417-426 (2002).
59. Jeon, T.I. & Osborne, T.F. SREBPs: metabolic integrators in physiology and metabolism. Trends in endocrinology and metabolism. TEM 23, 65-72 (2012).
60. Liang, G. et al. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277, 9520-9528 (2002).
61. Hong, C. et al. Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. J. Clin. Invest. 122, 337-347 (2012).
62. Joseph, S.B. et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119, 299-309 (2004).
63. Valledor, A.F. et al. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. USA 101, 17813-17818 (2004).
64. Yvan-Charvet, L. et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328, 1689-1693 (2010).
65. Westerterp, M. et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 11, 195-206 (2012).
66. Chukkapalli, V., Heaton, N.S. & Randall, G. Lipids at the interface of virus-host interactions. Curr. Opin. Microbiol. 15, 512-518 (2012).
67. Moog, C., Aubertin, A.M., Kirn, A. & Luu, B. Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro. Antivir. Chem. Chemother. 9, 491-496 (1998).
68. Pezacki, J.P. et al. Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chem. Biol. 9, 2 (2009).
69. Zeng, J., Wu, Y., Liao, Q., Li, L. & Chen, X. Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner. Antiviral Res. 95, 245-256 (2012).
70. Dubrovsky, L. et al. Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection. Biochem. Biophys. Res. Commun. 419, 95-98 (2012).
71. Morrow, M.P. et al. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol. Pharmacol. 78, 215-225 (2010).
72. Korf, H. et al. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J. Clin. Invest. 119, 1626-1637 (2009).
73. Bruhn, K.W. et al. LXR deficiency confers increased protection against visceral Leishmania infection in mice. PLoS Negl. Trop. Dis. 4, e886 (2010).
74. Park, K. & Scott, A.L. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 88, 1081-1087 (2010).
75. Diczfalusy, U. et al. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 50, 2258-2264 (2009).
76. Blanc, M. et al. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol. 9, e1000598 (2011).
77. Pereira, J.P., Kelly, L.M., Xu, Y. & Cyster, J.G. EBI2 mediates B cell segregation between the outer and centre follicle. Nature 460, 1122-1126 (2009).
78. Gatto, D., Paus, D., Basten, A., Mackay, C.R. & Brink, R. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity 31, 259-269 (2009).
79. Yi, T. et al. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 37, 535-548 (2012).
80. Conlon, P., Oksenberg, J.R., Zhang, J. & Steinman, L. The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system. Neurobiol. Dis. 6, 149-166 (1999).
81. Wang, L. et al. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. USA 99, 13878-13883 (2002).
82. Hindinger, C. et al. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 84, 1225-1234 (2006).
83. Teunissen, C.E. et al. Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci. Lett. 347, 159-162 (2003).
84. Kang, J. & Rivest, S. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors. Endocr. Rev. 33, 715-746 (2012).
85. Leoni, V. & Caccia, C. Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 164, 515-524 (2011).
86. Walcher, D. et al. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler. Thromb. Vasc. Biol. 26, 1022-1028 (2006).
87. Nagy, L., Szanto, A., Szatmari, I. & Szeles, L. Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol. Rev. 92, 739-789 (2012).
88. Hanley, T.M., Blay Puryear, W., Gummuluru, S. & Viglianti, G.A. PPAR? and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection. PLoS Pathog. 6, e1000981 (2010).
89. Geyeregger, R. et al. Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. Blood 109, 4288-4295 (2007).
90. Rabinovich, G.A., Gabrilovich, D. & Sotomayor, E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267-296 (2007).
91. Villablanca, E.J. et al. Tumor-mediated liver X receptor-? activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16, 98-105 (2010).
92. Feig, J.E. et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J. Clin. Invest. 120, 4415-4424 (2010).
93. Gatto, D. et al. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. Nat. Immunol. 14, 446-453 (2013).
94. Bard, M. et al. Cloning and characterization of ERG25, the Saccharomyces cerevisiae gene encoding C-4 sterol methyl oxidase. Proc. Natl. Acad. Sci. USA 93, 186-190 (1996).
95. Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507-3512 (2013).